superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
- Valid from
- 2022-10-31
- Valid until
- 2023-02-06
- Published
- 2022-11-04
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-08 · parsed from the SEC filing
- Confidence
- 0.95
- Replaced by
- 533,976,238 shares
Sources
Cite this claim
Plain text
AsOf. "Amgen shares outstanding: 533,579,206 shares", as of 2022-10-31 (until 2023-02-06). Claim clm_C279B018E45E, https://asof.is/claim/clm_C279B018E45E, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/318154/000031815422000055/0000318154-22-000055-index.htm.
APA
AsOf. (2022). Amgen shares outstanding: 533,579,206 shares (as of 2022-10-31 (until 2023-02-06)) [Record clm_C279B018E45E]. Retrieved November 8, 2026, from https://asof.is/claim/clm_C279B018E45E (source: https://www.sec.gov/Archives/edgar/data/318154/000031815422000055/0000318154-22-000055-index.htm)
BibTeX
@misc{asof_clm_C279B018E45E,
author = {AsOf},
title = {Amgen shares outstanding: 533,579,206 shares},
year = {2022},
howpublished = {\url{https://asof.is/claim/clm_C279B018E45E}},
note = {Claim clm\_C279B018E45E, as of 2022-10-31 (until 2023-02-06); source: https://www.sec.gov/Archives/edgar/data/318154/000031815422000055/0000318154-22-000055-index.htm},
urldate = {2026-11-08}
}Supersedes
On the record
/claim/clm_C279B018E45E.md/v1/claims/clm_C279B018E45Esubmit a correction